Answers are grounded in this paper and cite their sources.
Lysergic acid diethylamide (LSD) is a serotonergic psychedelic with active dosages in the microgram range. Accurate information about the LSD content of blotters is essential for harm reduction. However, drug checking services (DCS) across Europe have reported that service users expect LSD contents to be considerably higher than what is measured analytically, raising questions about the accuracy and reliability of current methods used in DCS settings. This study presents an interlaboratory ring trial on LSD quantification within the context of drug checking. Five Swiss DCS laboratories participated, each employing different analytical techniques (HPLC-DAD, GC-MS, and HPLC-MS/MS) and extraction procedures. Three sample types were distributed: two LSD-infused blotters and one methanolic LSD solution. The quantitative results were corrected based on purity determined by proton nuclear magnetic resonance spectroscopy (qNMR) of the reference standard. Interlaboratory variability was low, with relative standard deviations of 8%-16.5% and mean accuracy ranging from -5.3% to -13.0%. Variability was higher for the liquid sample. The largest deviations were reported for mass spectrometry-based methods. The study confirmed the reliability of LSD quantification across participating DCS laboratories. Additional factors that could potentially contribute to the reported discrepancy were discussed: limited stability of LSD, potential inconsistencies in clandestine blotter production methods, and user expectations shaped by marketing or anecdotal reports. The findings support the accuracy of current LSD quantification methods in drug checking settings and provide a foundation for future proficiency testing. Reliable chemical data is essential for accurate dosing and effective harm reduction.
No takes yet. Share an insight, caveat, or question.
Monti et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: